Has Jonathan Jennings, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,566 in general payments to Jonathan Jennings, MD across 35 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Jennings, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Jennings, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Jennings, MD

Internal Medicine · New York, NYNPI 1134381239

Payments from drug & device makers

$1,566in general payments, 2019–2025

Across 35 payments — averaging $44.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teva Pharmaceuticals USA, Inc.$489
Neurocrine Biosciences, Inc.$461
Viiv Healthcare Company$269
Gilead$195
AstraZeneca$46
Johnson & Johnson$43
plus $63 from 3 others

What the payments were for

Food & beverage$1,566100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teva Pharmaceuticals USA, Inc.	14	$489
Neurocrine Biosciences, Inc.	7	$461
Viiv Healthcare Company	3	$269
Gilead	4	$195
AstraZeneca	2	$46
Johnson & Johnson	2	$43
Amgen	1	$25
Smith+Nephew	1	$20
EMD Serono, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,566 in reported general payments places this provider in the 75th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Medicare billing

Part B allowed, 2024

$10,463

Medicare patients

Services billed

108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Atorvastatin Calcium	39	$460
Metoprolol Succinate	18	$264
Tamsulosin Hcl	14	$220
Pantoprazole Sodium	12	$176
Gabapentin	12	$120

Paid to pharmacies, not to this prescriber.

Other internal medicine in New York

Helena YuNew York$50.9M
Neha KordeNew York$21.2M
Karen AutioNew York$18.5M
Ingo MellinghoffNew York$16.1M
Gopakumar IyerNew York$12.4M
Sally LauNew York$8.4M
Maria RubinsteinNew York$6.3M
Dana RathkopfNew York$6M
Eytan SteinNew York$5.8M
James GreenwaldNew York$4.9M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →